
Non surgical mitral valve repair: First enrollment in ACCESS-Europe study
Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced the first enrollment in the ACCESS-Europe study, a post-market observational study of the MitraClip therapy in Europe. The system is the first commercially available treatment option for non-surgical mitral valve repair for patients suffering from the effects of functional and…